Skip to main content

Limitless X Holdings Inc.

corporate_fare Company Profile

Limitless X Holdings Inc.

LIMX·OTC·Trade & Services·CIK 0001803977

Limitless X Holdings, Inc. is a Delaware corporation that builds a diversified ecosystem across health, wellness, entertainment, and media-driven brand development. As of January 1, 2026, the Company operates through four wholly owned subsidiaries: Limitless X, Inc., Limitless Films, Inc., Limitless Entertainment Group, Inc., and BodyCor, Inc. Limitless X, Inc. operates a direct-to-consumer e-commerce platform for a diversified portfolio of health, wellness, and consumer packaged goods. It serves as the Company's primary commercial engine across direct-to-consumer, Amazon, and retail channels. The Company offers premium dietary supplements and lifestyle products for mass-market adoption, focusing on convenient delivery formats and repeat consumer use. Its product portfolio includes the NZT-48 line (NZT-48 Original, NZT-48 Lion's Mane, NZT-48 For Her, and NZT-48 NAD+ Gummies), OneShot Nootropic Pre-Workout, SuperSlim Gummies, HYDR8 Creatine + Hydration Gummies, SuperShrooms Functional Mushroom Gummies, Super Greens Daily Greens, and Nootropic Coffee Concentrates. These products address consumer demand for cognitive support, energy, recovery, weight management, and general wellness. Limitless X has agreements to develop signature premium supplement product lines for Manny Pacquiao and Paul Michael DelVecchio Jr. (DJ Pauly D). The Company is pursuing international expansion initiatives in the Middle East, the Philippines, and India. BodyCor, Inc. was established to consolidate and scale technology-driven wellness initiatives across the Limitless X ecosystem.

Limitless X Holdings Inc. (OTC:LIMX) is a publicly traded company in the Trade & Services sector. Wiseek has independently scored 12 items for LIMX at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-16, rated 8/10. Across its 12 most recent items scored 7 or higher, the top rating is 9/10, with 10 rated 8 or above. Recent SEC coverage for LIMX spans 10-Q, 8-K, 8-K/A, 10-K.

Recent high-impact activity:

  • Limitless X Q3 Revenue Collapses 90% to $23,623; Going Concern Reiterated
  • Limitless X Clears 14M Preferred Shares, Creates 20M Class F for $1.25 Reg A Units
  • Limitless X Q2 Revenue Collapses 86% as Losses Mount and Going Concern Warning Reiterated
  • Limitless X Reports Q1 Revenue Plunges 69% to $77.6K, Net Loss of $28.9M Continues
  • Limitless X Reports Q1 Loss of $28.9M, Confirms Going Concern, Secures New Dilutive Financing

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$946.56K
Net Income
-$46.12M
Diluted EPS
-$1.23
Op. Cash Flow
-$1.61M
Gross Profit
$712.98K
Operating Income
-$9.1M
Cash & Equivalents
$7.17K
Debt / Equity
0.00×
Net Margin
-48.72×
Shares Outstanding
16.99M sh
Source: 10-K · filed 2026-04-15 · accession 0001493152-26-016760

Short Interest & Short Volume

4.90 days to cover

FINRA reported short interest of 446 shares in LIMX as of the October 30, 2026 settlement, unchanged from the prior period — about 4.9 days to cover at its recent average daily volume. On November 20, 2026, 2.1% of LIMX volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)446 shares as of October 30, 2026
Change vs prior period 0.0%
Days to cover4.90 at avg daily volume of 91
Daily short volume (FINRA facilities)2.1% of 4,798 shares on November 20, 2026

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Dilution Risk

Moderate risk

Filing-implied dilution signals for LIMX, detected from its recent SEC filings · based on capital-structure filings through 2026-06-26.

Significant Net Loss and Accumulated Deficit · Going Concern Warning Reiterated

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

Browse all tickers starting with L →
$0.232 -6.83% today
52-week range · as of 2026-11-16 $0.126 – $4.37
Market cap
$5.34M
Volume
4.8K (0.8× avg)
3-mo avg 5.8K
Live data · 2026-11-22 12:36 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed LIMX - Latest Insights

LIMX
Nov 16, 2026, 5:22 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.249
Real-time Price: $0.232 info
Change: -$0.017 (-7%) info
Market Cap: $5.336M info
LIMX
Oct 23, 2026, 6:03 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.249
Real-time Price: $0.232 info
Change: -$0.017 (-7%) info
Market Cap: $5.336M info
LIMX
Aug 14, 2026, 1:49 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.700
Real-time Price: $0.232 info
Change: -$0.468 (-67%) info
Market Cap: $5.336M info
LIMX
Jun 26, 2026, 5:41 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $0.794
Real-time Price: $0.232 info
Change: -$0.562 (-71%) info
Market Cap: $5.336M info
LIMX
Jun 26, 2026, 5:30 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.794
Real-time Price: $0.232 info
Change: -$0.562 (-71%) info
Market Cap: $5.336M info
LIMX
Jun 05, 2026, 9:17 AM EDT
Filing Type: 8-K/A
Importance Score:
8
Price at Filing: $0.9499
Real-time Price: $0.232 info
Change: -$0.7179 (-76%) info
Market Cap: $5.336M info
LIMX
Apr 15, 2026, 2:16 PM EDT
Filing Type: 10-K
Importance Score:
9
Price at Filing: $1.20
Real-time Price: $0.232 info
Change: -$0.968 (-81%) info
Market Cap: $5.336M info
LIMX
Apr 09, 2026, 2:39 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.20
Real-time Price: $0.232 info
Change: -$0.968 (-81%) info
Market Cap: $5.336M info
LIMX
Feb 27, 2026, 6:08 AM EST
Filing Type: 8-K
Importance Score:
9
Price at Filing: $1.25
Real-time Price: $0.232 info
Change: -$1.02 (-81%) info
Market Cap: $5.336M info
LIMX
Feb 09, 2026, 8:55 AM EST
Filing Type: 8-K
Importance Score:
9
Price at Filing: $1.02
Real-time Price: $0.232 info
Change: -$0.788 (-77%) info
Market Cap: $5.336M info
LIMX
Jan 26, 2026, 7:13 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.04
Real-time Price: $0.232 info
Change: -$0.808 (-78%) info
Market Cap: $5.336M info
LIMX
Jan 08, 2026, 8:02 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.10
Real-time Price: $0.232 info
Change: -$0.868 (-79%) info
Market Cap: $5.336M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets